The role of SGOL1 in the prognosis of skin cutaneous melanoma (SKCM): SGOL1 在皮肤黑色素瘤(SKCM) 预后中的作用: 目的: 分析皮肤黑色素瘤(SKCM) 中SGOL1 的 …

L Xuankai, FU Shuying, C Hongda - 开元Medical-Research, 2022 - mrhk.cc
cutaneous melanoma (SKCM) is a major public health problem worldwide. Skin is one of
most common site of melanoma in China, skin cutaneous melanoma (… cutaneous melanoma is …

[HTML][HTML] 免疫相关的皮肤黑色素瘤预后模型构建及肿瘤免疫微环境分析

吴猛, 汪政, 张江林 - Journal of Central South University Medical …, 2023 - ncbi.nlm.nih.gov
… Skin cutaneous melanoma (SKCM) transcriptome sequencing data and corresponding
clinical information were obtained from the TCGA database, differentially expressed genes were …

当前位置: 首页> 期刊>《 新英格兰医药杂志》> 2006 年第13 期> 正文编号: 11332568 Molecular Mechanisms in Melanoma

SJ Diaz-Cano, M Bittner, P Meltzer, Y Chen - 100md.com
To the Editor: The review of melanoma by Miller and Mihm (July 6 issue) 1 clearly characterizes
the linear progression of melanocytic lesions, from the morphologic perspective to the …

[PDF][PDF] 授与番号甲第1762 号

転換の解析, 一郎, 的とした - Human Pathology, 2018 - iwatemed.repo.nii.ac.jp
… its clinicopathological relevance in cutaneous malignant tumors, … Here, we investigated the
CAF phenotype in cutaneous … of the CAF phenotype in cutaneous malignant cancers using …

[HTML][HTML] LncRNAs 在皮肤黑色素瘤中的生物学功能和潜在临床应用

牛常英, 乔友路, 刘烜凯, 张山, 谭慎兴 - World Journal of Cancer …, 2023 - hanspub.org
… the biological function of LncRNAs in cutaneous melanoma, and summarized and discussed
… new theoretical basis for new treatments and targeted RNA drugs for cutaneous melanoma. …

黏膜黑色素瘤基因组学研究进展

唐黎瑞, 代杰, 毛丽丽, 斯璐, 郭军 - 肿瘤综合治疗电子杂志, 2022 - jmcm2018.com
… In contrast, the drivers mutation in mucosal melanoma, … cutaneous melanoma driver gene
mutations. Here we summarized the published genomics and clinical research of the genomic

NRAS 突变型晚期黑色素瘤的治疗进展

赵博伦, 朱冠男 - 中国癌症杂志, 2023 - china-oncology.com
… 12 patients with NRAS-mutated cutaneous melanoma and 21 patients with NRAS-mutated
noncutaneous melanoma In cutaneous melanoma, patients with NRAS mutations had a …

[HTML][HTML] RITA 体外选择性抑制BAP1 缺失的皮肤黑色素瘤细胞的生长

石文惠, 刘小莲, 张贵明, 叶林萱, 周润华… - Journal of Southern …, 2023 - ncbi.nlm.nih.gov
… in the sensitivity of cutaneous melanoma cells to p53 activator RITA. In melanoma cells,
the … of melanoma cells, suggesting the potential of RITA as a targeted therapeutic agent for …

[PDF][PDF] GSDMBGSDMD在皮肤黑色素瘤中的表达及其与预后和免疫浸润的相关性分析

聂刚, 亓俊华 - 激光生物学报, 2023 - jgsw.hunnu.edu.cn
… 皮肤黑色素瘤(skin cutaneous melanoma, SKCM)是一种源于黑素细胞的恶性肿瘤,其恶性 程度
在皮肤恶性肿瘤中居首位.SKCM 转移率高, 预后差[1].据报道,转移性SKCM 患者中位生存期 <6 …

47 例皮肤黑色素瘤的临床与病理分析

齐曼丽, 冯俊明, 任勇, 梁励玮, 张鹏, 陈昕薇 - 肿瘤防治研究, 2013 - zlfzyj.com
… 皮肤黑色素瘤(cutaneous melanoma, CM)是起 源于皮肤黑色素细胞的恶性肿瘤,占皮肤肿瘤
死亡 病例的90%[1-2];近年来世界范围内白色人种的CM 发病率明显升高,据统计欧洲发病率为(10~…